1. Home
  2. ILMN vs PUK Comparison

ILMN vs PUK Comparison

Compare ILMN & PUK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • PUK
  • Stock Information
  • Founded
  • ILMN 1998
  • PUK 1848
  • Country
  • ILMN United States
  • PUK Hong Kong
  • Employees
  • ILMN N/A
  • PUK N/A
  • Industry
  • ILMN Medical Specialities
  • PUK Life Insurance
  • Sector
  • ILMN Health Care
  • PUK Finance
  • Exchange
  • ILMN Nasdaq
  • PUK Nasdaq
  • Market Cap
  • ILMN 13.1B
  • PUK 29.3B
  • IPO Year
  • ILMN 2000
  • PUK 1990
  • Fundamental
  • Price
  • ILMN $98.15
  • PUK $24.78
  • Analyst Decision
  • ILMN Buy
  • PUK
  • Analyst Count
  • ILMN 16
  • PUK 0
  • Target Price
  • ILMN $126.88
  • PUK N/A
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • PUK 1.1M
  • Earning Date
  • ILMN 08-05-2025
  • PUK 03-19-2025
  • Dividend Yield
  • ILMN N/A
  • PUK 1.87%
  • EPS Growth
  • ILMN N/A
  • PUK 35.70
  • EPS
  • ILMN N/A
  • PUK 0.84
  • Revenue
  • ILMN $4,337,000,000.00
  • PUK $12,256,000,000.00
  • Revenue This Year
  • ILMN N/A
  • PUK $131.26
  • Revenue Next Year
  • ILMN $3.11
  • PUK $13.17
  • P/E Ratio
  • ILMN N/A
  • PUK $14.07
  • Revenue Growth
  • ILMN N/A
  • PUK 11.04
  • 52 Week Low
  • ILMN $68.70
  • PUK $14.39
  • 52 Week High
  • ILMN $156.66
  • PUK $25.58
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 77.43
  • PUK 61.25
  • Support Level
  • ILMN $88.68
  • PUK $23.88
  • Resistance Level
  • ILMN $95.99
  • PUK $25.58
  • Average True Range (ATR)
  • ILMN 2.92
  • PUK 0.27
  • MACD
  • ILMN 0.67
  • PUK 0.01
  • Stochastic Oscillator
  • ILMN 86.09
  • PUK 52.65

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About PUK Prudential Public Limited Company

Originally established as Prudential Mutual Assurance, Investment, and Loan Association in 1848, Prudential plc has moved on a lot since then. Set up to sell life insurance and loans to the middle and then the industrializing and urbanizing working classes, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life in around 1985. During its time as owner of Jackson, Prudential focused on building out a simple chassis-style product portfolio where customers could choose a variety of add-ons. The company also became renowned for its focus on building requisite internal capabilities to support its strong product offerings, including compelling technology and a large and well-trained salesforce.

Share on Social Networks: